Avior Wealth Management LLC Has $350,000 Position in Kenvue Inc. (NYSE:KVUE)

Avior Wealth Management LLC reduced its stake in Kenvue Inc. (NYSE:KVUE) by 9.0% in the 4th quarter, Holdings Channel reports. The firm owned 16,279 shares of the company’s stock after selling 1,602 shares during the period. Avior Wealth Management LLC’s holdings in Kenvue were worth $350,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. acquired a new stake in Kenvue in the 3rd quarter worth approximately $2,944,816,000. FMR LLC lifted its holdings in shares of Kenvue by 572.1% during the third quarter. FMR LLC now owns 89,182,980 shares of the company’s stock worth $1,790,794,000 after buying an additional 75,913,107 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Kenvue by 576.1% during the third quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock worth $1,439,472,000 after buying an additional 61,084,123 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Kenvue by 227.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company’s stock worth $1,226,711,000 after buying an additional 42,449,470 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in shares of Kenvue by 4,057.4% during the third quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock worth $625,745,000 after buying an additional 30,413,040 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. The Goldman Sachs Group assumed coverage on Kenvue in a report on Friday, March 1st. They set a “neutral” rating and a $20.00 price target for the company. William Blair assumed coverage on Kenvue in a report on Wednesday, April 3rd. They set a “market perform” rating for the company. Royal Bank of Canada cut their price target on Kenvue from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 9th. JPMorgan Chase & Co. cut their price target on Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a report on Friday, February 9th. Finally, Sanford C. Bernstein initiated coverage on Kenvue in a research report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus target price of $24.85.

Kenvue Price Performance

Shares of Kenvue stock opened at $19.58 on Friday. Kenvue Inc. has a 1 year low of $17.82 and a 1 year high of $27.80. The business has a 50-day moving average of $19.84 and a two-hundred day moving average of $20.16. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The company had revenue of $3.67 billion during the quarter, compared to the consensus estimate of $3.78 billion. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. Analysts anticipate that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were issued a $0.20 dividend. The ex-dividend date of this dividend was Tuesday, February 13th. This represents a $0.80 annualized dividend and a dividend yield of 4.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.